
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1107 | 1092 | 1144 | 1112 | 1420 | 1909 |
Fund Return | 10.71% | 9.22% | 14.39% | 3.61% | 7.27% | 6.68% |
Place in category | 213 | 222 | 317 | 321 | 242 | 114 |
% in Category | 31 | 33 | 48 | 57 | 51 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VF CH Valiant Swiss Equities SPI I | 624.69M | 10.59 | 2.89 | 5.94 | ||
LO Institutional Strategies CH Swi | 497.1M | 2.04 | 4.02 | 5.01 | ||
LO Institutional Strategies CH Swis | 497.1M | -0.97 | 2.20 | 4.97 | ||
Avadis VermOgensbildung SICAV Strat | 274.28M | 1.93 | 2.35 | 3.73 | ||
CH0364960218 | 269.82M | 6.41 | -1.08 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.71B | 12.09 | 5.90 | 7.10 | ||
Pictet CH Institutional Swiss EquZD | 2.28B | 10.28 | 3.87 | 7.82 | ||
Pictet CH Institutional Swiss EquiZ | 2.28B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 2.28B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquiP | 2.28B | 8.84 | 1.85 | 7.84 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 12.32 | 98.24 | -0.19% | |
Roche Holding Participation | CH0012032048 | 12.21 | 306.00 | -1.03% | |
Nestle | CH0038863350 | 11.45 | 89.76 | -0.82% | |
Zurich Insurance Group | CH0011075394 | 5.59 | 609.80 | +0.46% | |
ABB | CH0012221716 | 5.29 | 51.08 | +3.03% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review